Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay

BackgroundThere is widespread interest in the use of innate immune modulators as a defense strategy against infectious pathogens. Using rotavirus as a model system, we developed a cell-based, moderate-throughput screening (MTS) assay to identify compounds that reduce rotavirus infectivity in vitro, toward a long-term goal of discovering immunomodulatory agents that enhance innate responses to viral infection.ResultsA natural product library consisting of 280 compounds was screened in the assay and 15 compounds that significantly reduced infectivity without cytotoxicity were identified. Time course analysis of four compounds with previously characterized effects on inflammatory gene expression inhibited replication with pre-treatment times as minimal as 2 hours. Two of these four compounds, α-mangostin and 18-β-glycyrrhetinic acid, activated NFκB and induced IL-8 secretion. The assay is adaptable to other virus systems, and amenable to full automation and adaptation to a high-throughput format.ConclusionIdentification of several compounds with known effects on inflammatory and antiviral gene expression that confer resistance to rotavirus infection in vitro suggests the assay is an appropriate platform for discovery of compounds with potential to amplify innate antiviral responses.

[1]  C. Hackett.  Innate immune activation as a broad-spectrum biodefense strategy , 2003, Journal of Allergy and Clinical Immunology.

[2]  Jeffrey B Ulmer,et al.  Targeting the innate immune response with improved vaccine adjuvants , 2005, Nature Medicine.

[3]  T. Arakawa,et al.  γ-Mangostin Inhibits Inhibitor-κB Kinase Activity and Decreases Lipopolysaccharide-Induced Cyclooxygenase-2 Gene Expression in C6 Rat Glioma Cells , 2004, Molecular Pharmacology.

[4]  N. Ishimura,et al.  9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor. , 2003, The Journal of laboratory and clinical medicine.

[5]  M. Hardy,et al.  Use of Early Passage Fetal Intestinal Epithelial Cells in Semi-High-Throughput Screening Assays: An Approach to Identify New Innate Immune System Adjuvants , 2006, Journal of biomolecular screening.

[6]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[7]  T. Hofmann,et al.  The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex , 1999, The Journal of Immunology.

[8]  T. Merigan,et al.  The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice. , 1970, The Journal of clinical investigation.

[9]  R. F. Ramig,et al.  Comparative studies of the antigenic polypeptide species VP4, VP6, and VP7 of three strains of bovine rotavirus , 1989, Journal of clinical microbiology.

[10]  R. Ward,et al.  Development of an improved method for measuring neutralizing antibody to rotavirus. , 1991, Journal of virological methods.

[11]  M. A. Fernández,et al.  Anti‐inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea , 2001, The Journal of pharmacy and pharmacology.

[12]  J. Lemm,et al.  Development of a Cell-Based High-Throughput Specificity Screen Using a Hepatitis C Virus-Bovine Viral Diarrhea Virus Dual Replicon Assay , 2005, Antimicrobial Agents and Chemotherapy.

[13]  B. Aggarwal,et al.  Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. , 1996, Journal of immunology.

[14]  Mark A. Miller,et al.  Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.

[15]  J. Gleye,et al.  Antibacterial activity of the leaves of Phyllanthus discoideus. , 1990, Journal of ethnopharmacology.

[16]  Paul A Johnston,et al.  Cellular platforms for HTS: three case studies. , 2002, Drug discovery today.

[17]  Tetsuro Ito,et al.  Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells. , 2004, Bioorganic & medicinal chemistry.

[18]  R. Yu,et al.  Abietic acid activates peroxisome proliferator‐activated receptor‐γ (PPARγ) in RAW264.7 macrophages and 3T3‐L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism , 2003, FEBS letters.

[19]  T. Hofmann,et al.  The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. , 1999, Journal of immunology.

[20]  P. Geppetti,et al.  Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function , 2004, British journal of pharmacology.

[21]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[22]  W. Blair,et al.  A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors. , 2005, Antiviral research.

[23]  G. Milo,et al.  Effect of cytokinins on tobacco mosaic virus production in tobacco pith tissue cultures. , 1969, Virology.

[24]  L. Babiuk,et al.  Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves , 1983, Journal of clinical microbiology.

[25]  K. Hertogs,et al.  Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus , 2005, Journal of Virological Methods.

[26]  F. Koehn,et al.  The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.

[27]  M. Barro,et al.  Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Peltz,et al.  Toward the Development of a Virus-Cell-Based Assay for the Discovery of Novel Compounds against Human Immunodeficiency Virus Type 1 , 2003, Antimicrobial Agents and Chemotherapy.

[29]  E. Williamson,et al.  Isopimaric acid from Pinus nigra shows activity against multidrug‐resistant and EMRSA strains of Staphylococcus aureus , 2005, Phytotherapy research : PTR.

[30]  J. Wijnberg,et al.  Antimalarial compounds containing an alpha,beta-unsaturated carbonyl moiety from Tanzanian medicinal plants. , 1990, Planta medica.

[31]  K. Muraki,et al.  Molecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit. , 2002, Molecular pharmacology.

[32]  E. Borden,et al.  Modulation of Interferon (IFN)-inducible Gene Expression by Retinoic Acid , 1996, The Journal of Biological Chemistry.

[33]  J. Rossen,et al.  Inhibition of Cyclooxygenase Activity Reduces Rotavirus Infection at a Postbinding Step , 2004, Journal of Virology.

[34]  R. Pompei,et al.  Glycyrrhizic acid inhibits virus growth and inactivates virus particles , 1979, Nature.

[35]  Hyun Pyo Kim,et al.  Anti-inflammatory plant flavonoids and cellular action mechanisms. , 2004, Journal of pharmacological sciences.

[36]  Brian J Eastwood,et al.  A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio , 2006, Journal of biomolecular screening.

[37]  Noel T. Whelan,et al.  Innate immunity for biodefense: A strategy whose time has come , 2005, Journal of Allergy and Clinical Immunology.

[38]  M. Hardy,et al.  Interferon Regulatory Factor 3 Is a Cellular Partner of Rotavirus NSP1 , 2002, Journal of Virology.